Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oncternal Therapeutics, Inc. has filed 1,606 SEC EDGAR filings since 21 Aug 2003

SEC filing history

Showing 626-650 of 1,000 matching filings.

Per page
25
Current page
26
8-K File 000-50549

8-K

Filing date
08 May 2015
Reporting date
08 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
23 Apr 2015
Reporting date
22 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
23 Apr 2015
Reporting date
23 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 Apr 2015
Reporting date
20 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
17 Apr 2015
Reporting date
13 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
15 Apr 2015
Reporting date
15 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-79588

NONE

Filing date
13 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
13 Apr 2015
Reporting date
10 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 000-50549

AUTO-GENERATED PAPER DOCUMENT

Filing date
07 Apr 2015
Reporting date
31 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-79588

NONE

Filing date
06 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-79588

NONE

Filing date
03 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
02 Apr 2015
Reporting date
01 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
02 Apr 2015
Reporting date
01 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
02 Apr 2015
Reporting date
02 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-50549

DEF 14A

Filing date
26 Mar 2015
Reporting date
06 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
20 Mar 2015
Reporting date
16 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-50549

PRE 14A

Filing date
06 Mar 2015
Reporting date
06 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Mar 2015
Reporting date
02 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
04 Mar 2015
Reporting date
02 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
04 Mar 2015
Reporting date
27 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
04 Mar 2015
Reporting date
04 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
20 Feb 2015
Reporting date
18 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
20 Feb 2015
Reporting date
18 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
20 Feb 2015
Reporting date
18 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .